McKesson Corporation

683.41
-13.67 (-1.96%)
At close: Apr 21, 2025, 3:59 PM
682.49
-0.13%
After-hours: Apr 21, 2025, 05:54 PM EDT

McKesson Revenue Breakdown

Period Ending Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Dec 31, 2011
International Segment Revenue 3.71B 3.55B 3.64B 3.48B 3.47B 3.36B 4.45B 6.24B 6.55B 8.53B 9.46B 9.11B 9.25B 17.15B 9.27B 9.54B 1.8B 2.21B 2.14B 2.06B 1.9B 1.96B 2.01B 1.95B 1.7B 1.44B 1.44B 1.56B 1.53B 1.38B 1.36B 1.46B 1.47B 1.36B 1.07B 874M 873M 795M 760M
International Segment Revenue Growth +4.54% -2.50% +4.72% +0.20% +3.12% -24.41% -28.67% -4.76% -23.22% -9.83% +3.85% -1.48% -46.09% +84.97% -2.80% +429.71% -18.32% +2.99% +4.13% +8.04% -2.66% -2.83% +3.29% +14.39% +18.26% +0.28% -8.18% +2.36% +10.80% +1.25% -6.84% -0.34% +8.11% +26.94% +22.31% +0.11% +9.81% +4.61% n/a
Medical-Surgical Solutions Segment Revenue 2.95B 2.84B 3.03B 2.83B 2.61B 2.69B 2.99B 2.84B 2.59B 2.87B 3.08B 3.12B 2.53B 2.71B 3.05B 2.53B 45.06B 46.27B 46.92B 45.98B 44.16B 40.9B 44.28B 41.61B 40.98B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Medical-Surgical Solutions Segment Revenue Growth +3.91% -6.40% +6.95% +8.54% -2.90% -9.95% +5.03% +9.68% -9.81% -6.75% -1.34% +23.58% -6.75% -11.23% +20.57% -94.38% -2.62% -1.38% +2.05% +4.11% +7.99% -7.64% +6.41% +1.54% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Prescription Technology Solutions Revenue 1.26B 1.18B 1.21B 1.14B 1.24B 1.18B 1.12B 1.02B 1.07B 1.02B 1.03B 932M 881M 1.45B 777M 668M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Prescription Technology Solutions Revenue Growth +7.20% -2.07% +5.70% -8.36% +5.25% +5.44% +10.12% -4.50% +4.51% -1.07% +10.62% +5.79% -39.03% +85.97% +16.32% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
U.S. Pharmaceutical Segment Revenue 85.73B 68.79B 73.02B 69.77B 67.16B 61.68B 61.93B 60.06B 56.95B 53.68B 55.04B 53.41B 50.02B 46.65B 49.49B 48.07B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
U.S. Pharmaceutical Segment Revenue Growth +24.62% -5.80% +4.67% +3.88% +8.89% -0.42% +3.12% +5.46% +6.09% -2.48% +3.05% +6.78% +7.22% -5.75% +2.97% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017 Mar 31, 2016
International Segment Revenue 14.13B 20.6B 36.34B 35.97B 38.34B 38.02B 38.41B 34.1B 32.63B
International Segment Revenue Growth -31.40% -43.33% +1.06% -6.20% +0.84% -1.02% +12.63% +4.52% n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.03B 2.5B 1.9B 2.09B 2.51B 2.09B 1.87B 1.96B 1.9B 1.95B 1.96B 2.53B 3.1B 2.67B 2.23B 2.22B 2.29B 2.24B 2.1B 2.4B 2.54B 2.22B 2.15B 2.86B 1.93B 1.8B 1.91B 2.22B 1.98B 2.01B 1.96B 2.01B 1.98B 1.89B 1.94B 1.91B 1.95B 1.89B 1.92B 2.07B
Selling, General, and Administrative Revenue Growth -18.98% +32.08% -9.37% -16.56% +19.79% +11.87% -4.79% +3.21% -2.41% -0.46% -22.60% -18.49% +16.34% +19.58% +0.36% -2.92% +2.41% +6.32% -12.44% -5.21% +14.24% +3.35% -24.98% +48.14% +7.45% -5.77% -13.98% +11.79% -1.24% +2.29% -2.14% +1.31% +5.04% -2.53% +1.36% -2.20% +3.28% -1.41% -7.26% n/a
Research and Development Revenue n/a n/a n/a 77M n/a n/a n/a 89M n/a n/a n/a 70M n/a n/a n/a 74M n/a n/a n/a 96M n/a n/a n/a 71M n/a n/a n/a 125M n/a n/a n/a 341M n/a n/a n/a 392M n/a n/a n/a 392M
Research and Development Revenue Growth n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a